Clinically relevant molecular subtypes in leiomyosarcoma

PURPOSE: Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Cancer Res
Main Authors: Guo, Xiangqian, Jo, Vickie Young, Mills, Anne M., Zhu, Shirley X., Lee, Cheng-Han, Espinosa, Inigo, Nucci, Marisa Rose, Varma, Sushama, Forgó, Erna, Hastie, Trevor, Anderson, Sharon, Ganjoo, Kristen, Beck, Andrew H., West, Robert B., Fletcher, Christopher, van de Rijn, Matt
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526352/
https://ncbi.nlm.nih.gov/pubmed/25896974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-3141
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍